ATAI

NASDAQStock

Atai Beckley N.V

$3.71-0.11 (-2.84%)

52-Week Range

$1.21
$6.45

Key Stats

Market Cap

700.7M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.62

Volume

2.1M

Avg Volume

5.7M

Performance

1M

-3.78%

3M

-7.73%

6M

-17.85%

YTD

-1.29%

1Y

+174.82%

3Y

+223.73%

5Y

-80.36%

Price Chart

ETF Exposure

ATAI is held by 16 ETFs

ETFFund NameWeight
PSILAdvisorShares Psychedelics ETF10.49%
BBCVirtus Biotech Clinical Trials ETF0.71%
FPXEFirst Trust IPOX Europe Equity Opportunities ETF0.13%
IBBiShares Biotechnology ETF0.10%
BIBProShares - Ultra Nasdaq Biotechnology0.08%
KBFRInnovator U.S. Small Cap Managed 10 Buffer ETF0.07%
EHLSEven Herd Long Short ETF0.06%
GWXState Street SPDR S&P International Small Cap ETF0.05%
ISCGiShares Morningstar Small-Cap Growth ETF0.04%
JKKiShares Morningstar Small-Cap Growth ETF0.04%
ISCBiShares Morningstar Small-Cap ETF0.02%
JKJiShares Morningstar Small-Cap ETF0.02%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.01%
WSMLiShares MSCI World Small-Cap ETF0.01%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.00%
AVUSAvantis U.S. Equity ETF0.00%

About ATAI ETF Exposure

Atai Beckley N.V (ATAI) is held by 16 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 700.7M, ATAI is a widely held institutional stock. The stock currently trades at $3.71. Investors can gain exposure to ATAI through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ATAI, sorted by portfolio weight.